Navigation Links
ABT is the Only Source for Kelo-cote(R) Advanced Formula Scar Gel

CLEARWATER, Fla., June 25 /PRNewswire/ -- Kelo-cote(R) advanced formula scar gel is a unique patented silicone formula using cross-link technology and has become the gold standard for scar treatment and abnormal scar prevention. The patented silicone formula in Kelo-cote(R) advanced formula scar gel is ONLY available from Advanced Bio-Technologies, Inc.(ABT).

Kelo-cote(R) is no longer available under the Dermatix label. Doctors and customers should not be misled by competitors' claims they offer the same product. Specifically, Valeant Pharmaceutical's claim that Dermatix and Dermatix Ultra contain the same formula or an improvement of Kelo-cote(R) advanced formula scar gel is FALSE. Dermatix and Dermatix Ultra are not manufactured by ABT and neither contains the Kelo-cote(R) formula.

Prior to July 2007, Kelo-cote(R) was available under the Dermatix label, but Valeant's license to market Kelo-cote(R) was terminated. Doctors should be aware that clinical data published under the brand name Dermatix prior to July 2007 was conducted using the current Kelo-cote(R) formula, but Kelo-cote(R) is no longer available under the Dermatix label.

To ABT's knowledge and belief, neither Dermatix nor Dermatix Ultra have clinical evidence supporting its efficacy. Kelo-cote(R) advanced formula scar gel has the ONLY clinically proven patented self-drying silicone formulation that creates a flexible, breathable silicone gel sheet. This is the reason Kelo-cote(R) advanced formula scar gel from ABT is the gold standard for scar treatment and prevention.

Kelo-cote(R) is manufactured by Advanced Bio-Technologies, Inc. headquartered in Clearwater, FL.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Lisa Massaad

SOURCE Advanced Bio-Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Decision Resources, Inc. Acquires Manhattan Research
2. Energetiqs Laser-Driven Light Source Technology Enables Continuous Spectrum Light Sources, from Visible to Deep Ultraviolet
3. New discoveries, new labs highlight international Canadian Light Source meeting
4. Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs
5. MAP Pharmaceuticals Appoints Marco Rosa Vice President of Human Resources
6. Engineers demonstrate first room-temperature semiconductor source of coherent Terahertz radiation
7. Eklin Announces Acquisition of Ultrasource, Inc.
8. Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
9. Global Blood Resources On-Line Calculator Reveals Wasted Blood Costs by Blood Salvage Machines During Heart Surgery to be in the Billions
10. /C O R R E C T I O N from Source -- Resverlogix Corp./
11. ETEX Announces Supply Agreement with AlloSource
Post Your Comments:
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
Breaking Biology Technology:
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
Breaking Biology News(10 mins):